"AMRN's BO price will be zero. No one will pay anything for AMRN.
Lovaza is superior and WAY cheaper to produce.
No one needs to pay AMRN anything to sell pure EPA, anyone can sell it without prescription tomorrow and any big pharma can run a couple of trials and go around or crush AMRN's laughable patents in the courts.
Big Pharma does not pay a dime more than they have to for anything.
But since pure EPA can't possibly be profitable with generic Lovaza on the market, no one will bother.
They will just sit back and laugh at Amarin going bankrupt trying to sell this economically worthless product."
-From AMRN's Yahoo message board..